Research Sites

Clinical trial recruitment source launch checklist

A recruitment source launch checklist for sites reviewing approved copy, routing, ownership, source quality, and reporting.

Every new recruitment source should launch with clear language, routing, attribution, ownership, duplicate handling, quality review, and stop criteria.

Download the recruitment source launch checklist

A printable checklist for launching a new source with approved language, routing, attribution, duplicate handling, ownership, quality review, and pause criteria.

Download checklist
In this guide

Key points

  • Do not launch a source until routing, owner alerts, and source attribution are tested.
  • Approved language, referral expectations, and patient handoff boundaries should be clear before outreach begins.
  • Source quality should be reviewed by movement and readiness, not only by raw inquiry count.

Confirm approved language and expectations

Before a source launches, confirm the approved recruitment language, study description, contact path, privacy boundary, and what the source is allowed to say about the study.

The source should not promise eligibility, enrollment, compensation, medical benefit, or a specific appointment outcome unless the approved materials support that language.

Test routing before volume arrives

The checklist should verify where inquiries land, which fields arrive, whether source attribution is captured, who gets notified, how duplicates are detected, and what happens if a record is incomplete.

A test inquiry before launch is often the simplest way to catch broken routing while there is still time to fix it.

Set ownership and service levels

A source launch should include first-response expectations, owner assignment, backup coverage, no-response cadence, and escalation criteria.

If a new source creates volume but no ownership rule, it can make the queue look busier while producing slower patient follow-up.

Measure quality by movement

Source quality should be reviewed through response rate, prescreen completion, records readiness, scheduling movement, screen-failure patterns, close reasons, and stale risk.

Raw volume is useful, but it does not tell the team whether a source is creating reviewable candidates or avoidable workload.

Define pause and shutdown criteria

Before launch, agree on when a source should be paused, revised, or stopped. Examples include repeated wrong-study inquiries, low response after follow-up, poor records readiness, high duplicate rate, or misleading source expectations.

That makes source management an operating discipline instead of a monthly debate about whether volume feels good or bad.

Sources and editorial notes

Published .

Written for site operations and source-quality review. It does not endorse any specific outreach channel or replace sponsor or IRB requirements.

This guide explains recruitment work and questions to discuss with your team.

This information is educational. Your study team makes medical, eligibility, and enrollment decisions.

See TrialsNest in action

Bring this workflow into one place.

Manage inquiries, follow-ups, records, and visits. Keep sponsors updated on progress.

Site clinical operations

Coordinator Today

Your inquiries, priorities, and upcoming visits.

Inquiries assigned
14
3 pending review
Visits today
6
4 in person · 2 virtual
Action priorities
4
Needs attention
Active studies
3
Study A · B · C
Daily priorities

Priority tasks

  • Review screening intakeInquiry 001 · Study A
    Completed
  • Verify specimen preparationStudy A · Due 10:00 AM
    Completed
  • Confirm visit windowInquiry 003 · Follow-up
    Pending
Today’s schedule

Upcoming visits

  1. In personInquiry 001

    Study A · Baseline visit

    View visit details →
  2. TelehealthInquiry 003

    Study A · Prescreen

    Review appointment →
  3. In personInquiry 004

    Study B · Week 4

    View visit details →

Keep reading